What is Neurofibromatosis

TL;DR: Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue throughout the body, often leading to skin changes, bone abnormalities, and neurological complications. While there is no cure, the 725 members of the DiseaseMaps community living with Neurofibromatosis demonstrate that proactive, multidisciplinary care can significantly improve quality of life and long-term outcomes.

What exactly is Neurofibromatosis?

Neurofibromatosis refers to a family of three distinct genetic disorders—NF1, NF2, and schwannomatosis—that share the common feature of tumor development along the nervous system. These tumors are typically benign (non-cancerous), but they can cause significant health challenges by pressing on nerves or organs, affecting skin pigmentation, and altering bone development. Because the nervous system is ubiquitous, the effects of Neurofibromatosis can manifest in almost any part of the body, making it a multisystem condition that requires coordinated care from various specialists.

What are the main types of Neurofibromatosis?

Clinicians classify this condition into three primary types based on their genetic cause and clinical presentation:

• Neurofibromatosis type 1 (NF1): The most common form, often characterized by café-au-lait spots (light brown skin patches) and neurofibromas (tumors) on or under the skin. It occurs in approximately 1 in 3,000 people.


• Neurofibromatosis type 2 (NF2): Primarily characterized by tumors on the nerves responsible for balance and hearing (vestibular schwannomas), which can lead to hearing loss and balance issues. It is much rarer, affecting roughly 1 in 25,000 to 40,000 individuals.


• Schwannomatosis: A rare form primarily causing chronic pain due to multiple schwannomas (tumors on nerve sheaths), usually excluding the vestibular tumors seen in NF2.

How does Neurofibromatosis affect the body?

The pathophysiology of Neurofibromatosis involves mutations in genes that act as "tumor suppressors." Normally, these genes produce proteins that prevent cells from growing and dividing too rapidly. When these genes are mutated, the body loses this "brake" system, allowing tumors to grow. The impact on the body varies widely: some individuals experience mild skin manifestations, while others may face complex issues such as vision impairment, skeletal deformities like scoliosis, hypertension, or learning disabilities. It is important to note that the severity of Neurofibromatosis is highly variable, even among family members with the same genetic mutation.

Who is typically affected by this condition?

Neurofibromatosis affects individuals regardless of gender, ethnicity, or geographic location. While NF1 is often diagnosed in early childhood due to the appearance of skin markers, NF2 and schwannomatosis may not present symptoms until late adolescence or early adulthood. Because it is a genetic condition, it can be inherited from a parent in an autosomal dominant pattern (a 50% chance for each child), though in about 30% to 50% of new cases, the condition arises from a spontaneous genetic mutation with no prior family history.

Next steps

• Consult a specialist: Seek a referral to a geneticist or a neurologist who specializes in phakomatoses (neurocutaneous syndromes).


• Join our community: Connect with the 725 members of the DiseaseMaps community to share experiences and coping strategies.


• Screening: Discuss a personalized surveillance plan with your doctor, as early detection of tumor growth is key to successful management.


• Support: Reach out to organizations like the Children’s Tumor Foundation for educational resources and clinical trial information.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): rarediseases.info.nih.gov


• Orphanet: Portal for rare diseases and orphan drugs: orpha.net


• Online Mendelian Inheritance in Man (OMIM): omim.org


• Children’s Tumor Foundation: ctf.org